CIK 1574661
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2016-Q2. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 42.29% | 6 |
| Health Care Equipment & Supplies | 33.90% | 2 |
| Unclassified | 23.82% | 3 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | EW | Edwards Lifesciences Corp | Health Care | 26.11% |
| 2 | ACAD | ACADIA PHARMACEUTICALS INC | Health Care | 14.47% |
| 3 | ARATANA THERAPEUTICS INC. | Unclassified | 12.79% | |
| 4 | JNJ | JOHNSON & JOHNSON | Health Care | 9.61% |
| 5 | DXCM | DEXCOM INC | Health Care | 7.79% |
| 6 | LLY | ELI LILLY & Co | Health Care | 6.68% |
| 7 | TESARO INC. | Unclassified | 6.27% | |
| 8 | ZTS | Zoetis Inc. | Health Care | 5.17% |
| 9 | BIIB | BIOGEN INC. | Health Care | 5.09% |
| 10 | ALEXION PHARMACEUTICALS INC | Unclassified | 4.75% |
8/11 names classified · sector 76.2% of weight · industry 76.2% · mkt cap 76.2%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 76.2% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 76.2% of book weight (8/9 names) · unclassified 23.8%: . Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | EWEDWARDS LIFESCIENCES CORP | 34,611 | $4M | 26.1% | ADD 86% |
| 2 | ACADACADIA PHARM | 72,723 | $2M | 14.5% | TRIM −12% |
| 3 | ARATANA THERAPEUTICS INC. | 218,515 | $2M | 12.8% | HOLD |
| 4 | JNJJOHNSON & JOHNSON | 13,000 | $2M | 9.6% | HOLD |
| 5 | DXCMDEXCOM | 14,200 | $1M | 7.8% | ADD 21% |
| 6 | LLYELI LILLY & CO | 13,310 | $1M | 6.7% | TRIM −50% |
| 7 | TESARO INC. | 10,000 | $1M | 6.3% | NEW |
| 8 | ZTSZOETIS INC | 15,900 | $827,000 | 5.2% | NEW |
| 9 | BIIBBIOGEN INC | 2,600 | $814,000 | 5.1% | NEW |
| 10 | ALEXION PHARMACEUTICALS INC | 6,199 | $760,000 | 4.8% | TRIM −28% |
| 11 | REGNREGENERON PHARMACEUTICALS | 500 | $201,000 | 1.3% | NEW |
Where this firm's principals came from and which firms its alumni went on to found.
